What Is Tirzepatide, and Which Peptides Are Most Similar?

Tirzepatide peptide 30 mg is a synthetic compound designed to act as a dual agonist, targeting both GLP-1 and GIP receptors. This mechanism supports improved blood sugar control and promotes weight loss, making it a promising option in metabolic and obesity-related research. This dual action allows tirzepatide to target multiple metabolic pathways, making it a promising candidate in the treatment of metabolic disorders beyond diabetes, including obesity. GLP-1 (glucagon-like peptide-1) GIP (glucose-dependent insulinotropic polypeptide) It was developed primarily for the management of type 2 diabetes mellitus (T2DM) and has shown strong weight loss benefits. Mechanism of action : GLP-1 receptor activation : Increases insulin secretion Suppresses glucagon secretion Slows gastric emptying Enhances satiety GIP receptor activation : Further enhances insulin response May improve fat metabolism and overall metabolic regulation By targeting both incretin receptors, tirzepatide provides Improv...